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ABSTRACT 
 
Objectives.  The trend towards more accountable care puts pressure on hospitals to 
manage care episodes, including the risk of readmission.  The emphasis on reducing 
readmissions implies that an association exists between the utilization of hospital 
resources and readmission risk.  This study was designed to explore this association in 
a cohort of pediatric asthma patients. 
Materials/Methods.  The sample cohort (n=4965) included all asthma discharges from 
January 2008 through August 2012 discharged from Children’s Hospitals and Clinics of 
Minnesota (CHC MN).   Asthma discharges included cases with a principal diagnosis of 
asthma or certain respiratory cases with asthma listed as a secondary diagnosis.  
Multiple logistic regression was used to test associations, adjusting for covariates. 
Results.  Adjusting for covariates, we found no significant association between initial 
length of stay (ILOS) and readmission (OR:1.04[95%CI:0.98-1.10]).  Analyzing ILOS 
categorically by day, one-day stays did not have a significantly higher readmission risk 
(OR:1.27[95% CI: 0.87-1.85]) than two-day stays, which had the lowest observed 
readmission risk.  Risk increased as ILOS exceeded 2 days but was not significantly 
different by day.   We found no association when comparing the difference in actual vs 
expected ILOS and readmission risk (shorter than expected OR:1.13[95%CI:0.74-1.71]; 
longer than expected OR:0.97[95%CI:0.69-1.38]). 
Conclusions. Altering ILOS is not likely to reduce readmissions in pediatric asthma 
patients.  For example, increasing one-day visits to two-day visits would increase 
hospital patient days 38%  (1870 days) in this cohort while decreasing total readmissions 
by 3.8%[95%CI:3.6-4.0%].  Attempts to prolong ILOS would dramatically increase costs 
with little reduction in readmissions.  
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BACKGROUND AND SIGNIFICANCE 
 Preventable readmissions have been identified as a potential indicator of quality 
of care and patient health and well being, though disagreement remains (Ashton, 1996; 
Benbassat, 2000; Goldfield, 2008; Berenson, 2010).  Some researchers remain skeptical 
regarding the level of readmissions that are truly preventable (VanWalRaven, 2011) as 
well as the association between hospital care and readmission risk  (Kossovsky, 2000; 
Joynt, 2010).   Despite this, payers (including Medicaid and commercial plans) are 
incorporating financial incentives into hospital contracts that are designed to reduce 
readmissions.   Such incentives include “bundled payments” and accountable care 
models that move away from traditional fee for service payment towards paying 
providers for successful treatment of an episode of care (Berkowitz, 2011; Cutler 2012). 
 While CMS has utilized an Inpatient Prospective Payment System (IPPS) 
historically to cap payments for treatment of conditions based upon condition severity, 
payers in general have not penalized hospitals for potentially preventable readmissions.  
In 2007 (responding to the 2005 Deficit Reduction Act), Medicare developed Hospital 
Acquired Conditions/Present on Admission (HAC/POA) rules that prevent the 
assignment of higher reimbursements for treatment of hospital-acquired conditions.  
Some state Medicare programs as well as private payers followed suit (Keefe, 2008).  
Under the Patient Protection and Affordable Care Act (2010), Medicaid regulations 
prohibit Federal payments to states for amounts expended for treating  Health-Care 
Acquired Conditions (HCAC).  The final rule issued June 30, 2011, requires states to 
implement non-payment policies for provider-preventable conditions (PPCs) including 
HCACs (CMS, 2011).  Recently, Medicare penalized 2,211 hospitals for excess 
readmission rates applied through global reimbursement reductions (Rau, 2012). 
 While meaningful research on the impact of readmissions on quality of care and 
cost has been conducted among the general adult inpatient population, more research is 
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needed to understand the nature and impact of readmissions on pediatric patients and 
hospitals (Gay 2011). The nature, treatment and ongoing care for childhood disease can 
differ substantially from the care and treatment of adults suggesting the need for further 
study (Vest, 2012).  Recent research in this area further confirms that the volume of 
readmission is significantly lower than for the adult population and that only a small sub-
population (~20%) of pediatric readmissions may actually be preventable (Hain, 2013). 
 The Ohio Children’s Hospitals Solutions for Patient Safety (OCHSPS) is a 
national collaborative of children’s hospitals that have organized to improve patient 
safety.  The mission of this federally-funded hospital engagement network (HEN) is to 
“work together to accelerate cultural and process improvements to eliminate serious 
harm across all children’s hospitals in the United States.” Under an agreement with 
CMS, efforts are focused on reducing the level of hospital-acquired conditions in 11 
specific areas, including preventable readmissions (Lyren, 2012).  
 Children’s Hospitals and Clinics of Minnesota (CHC MN), along with the Primary 
Children’s Medical Center in Utah, were selected to lead the effort to reduce preventable 
readmissions on behalf of the collaborative. CHC MN is a large, independent children’s 
hospital system located in Minneapolis.  CHC MN is a safety net hospital, serving the 
urban needs of poorer, more diverse, multi-racial and multilingual residents in the Twin 
Cities and the upper Midwest.   Services include general inpatient, emergency and home 
health care, as well as specialty care, including ICU, NICU and Cardiac ICU.   CHC MN 
inpatient services treat about 13,000 patients annually along with 200,000 ER visits and 
outpatient visits (CHC MN, 2012). 
 This study was conducted as part of the broader effort being made by OCHSPS 
and CHC MN to understand the impact of readmissions on the pediatric population.  IRB 
approval was obtained through CHC MN (IRB# 1207-067) and the University of 
Minnesota (IRB# 1209E20042). 
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UNDERSTANDING READMISSIONS 
 A readmission is generally defined as a rehospitalization within a given 
established time frame (3, 7, 15, 30, 45-days+).  This study focuses on the measurement 
of a 30-day readmission standard given its use by CMS in measurement of chronic 
treatment in adults (CMS, 2011).   Previous research into the primary causes of 
readmissions in the adult population point to a number of risk factors grouped into 
patient demographics, disease characteristics and care received.  Patient demographics 
identified as risk factors in previous studies include age, race, socio-economic status 
and hospital proximity.  Disease characteristics include type and severity of disease, 
presence of mental health, substance abuse or other co-morbidities.  Factors related to 
care include length of time between initial admit and readmission, prior use of hospital 
resources,  patient self-management, hospital admission rates, hospital capacity and the 
presence of a transition care plan (Jencks, 2009). 
 Among studies focused specifically on readmission risk on children, primary risk 
factors for readmission include the presence of complex comorbid conditions, race and 
use of medicaid (Feudtner, 2009; Mackie, 2008; Czaja, 2009).  These risk factors are 
consistent with studies of pediatric asthma patients (Reznick, 2006; Marcos, 2006;  
Carroll, 2010; Liu, 2009 ).  Despite this research, estimating readmission risk remains a 
“complex endeavor” that is still “poorly understood” (Kansagara, 2011). 
 
UNDERSTANDING PEDIATRIC ASTHMA 
 Asthma remains the most common chronic condition for children and a significant 
driver of hospitalizations. Over 10 million U.S. children aged 17 and under (14% of the 
population) have been diagnosed with asthma at one point in their lives; 7 million 
children still have asthma (10%). Boys are more likely than girls (16% vs 12%) to have 
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ever been diagnosed and the disease weighs disproportionately on non-Hispanic 
Black/African-American children (Bloom, 2011).  Despite the high prevelance of asthma 
in children, diagnosis and treatment of asthma remains a challenge.  
 Natural History.  An international consensus report on childhood asthma defines 
asthma as “repeated attacks of airway obstruction and intermittent symptoms of 
increased airway responsiveness to triggering factors, such as exercise, allergen 
exposure and viral infections.”  Given the “transient nature” of the condition, “the 
definition of asthma remains difficult to apply confidently in infants and preschool age 
children who present with recurrent episodes of coughing and/or wheezing” (Bacherier, 
2008). The underlying pathophysiology is a chronic tissue inflammation of the  airways 
that leads to impaired breathing.  The condition is rooted in the immune system which 
overreacts in response to the presence of certain triggers.   T-cell immunity remains a 
primary driver of inflammation as eosinophils, neutrophils and T cells enter the 
epithelium as an immune response, leading to inflammation.   Many asthmatic children 
are atopic with a tendency to develop IgE antibodies and  a Th1/Th2 imbalance in 
response to mitogens, allergens and viruses.   A step-wise participation of most, if not 
all, components of the immune and inflammatory response, including T-cells, moncytes, 
eosinophils, cytokines, chemokines and arachidonic acid metabolites is common. Our 
understanding of the pathogensis of allergic disorders, including asthma, continues to 
grow rapidly with our increasing understanding of underlying immune-response (Kay, 
et.al, 2008).  However, understanding the specific triggers for an individual is not always 
known. 
 Risk Factors.  Research into risk factors suggest that genetic factors, 
environmental factors, lifestyle factors, infections, tobacco smoke, pollutants, nutrition, 
irritants, exercise, weather and stress (both the child’s and the caregivers) are all 
associated with asthma.  Evidence also suggests that concurrent triggers may may be 
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additive.  Effective patient self-management, use of drug therapies and access to 
primary care can minimize asthma hospitalizations.  Persistent asthma also remains 
most prevalent among children who are poor, non-hispanic black or in overall poorer 
health (Berry, 2011).  High-risk profiles for asthma ICU readmissions include children 
who are overweight, non-caucasian and on public insurance (Carroll, 2010). 
 Diagnosis.  Diagnosing and treating childhood asthma remains challenging with 
“no specific diagnostic tools or surrogate markers” for early detection in infants.  Given 
the high prevelance and transient nature of coughing and wheezing in small infants and 
young children,  diagnosis in younger children is usually only possible through long-term 
follow up and the child’s respones to asthma treatment regimens.   Case history, along 
with a physicial examiniation, allergy testing and chest x-rays are the most common 
tests used for diagnosing pediatric asthma.    The most common measures of lung 
function include peak expiratory volume (PEF) and forced expiratory flow volume loop.  
Such measurement techniques are most useful in children above the ages of 5-6 years 
(Bacherier, 2008).  
 Treatment.  Primary efforts aimed at managing asthma include removing the 
particular triggers that cause the allergic response.  Evidence on the results of 
avoidance programs show conflicting results, particularly when weighed against the 
efforts required to maintain complete avoidance.  However, avoidable allergens, 
including pets, dust, food , as well as triggers, like tobacco smoke, can be avoided with 
demonstrated benefit (Chan-Yeung, 2005).  Pharmacological treatments include use of 
reliever and controller medications to manage symptoms and to reduce the risk of an 
episode.  Reliever medications (also known as bronchodialators) include short acting 
inhaled β2 agonists and are used as a more immediate response to heightening 
symptoms. Beta-2 agonists interact with beta-2 receptors to stimulate expansion of 
bronchi.  These treatments are generally administered through an inhaler or nebulizer.  
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Oral controller medications (corticosteroids) are used systemically the excesses of 
inflammatory response and reduce the risk of asthma exacerbations.  Reaction to the 
use of these medications can differ widely by child given a number of risk factors (HHS, 
2007). Immunotherapy is also a treatment for allergy-related exacerbations in an effort to 
reduce sensitization to known allergens over time.  Self-management education has also 
been shown to improve outcomes (Bacherier, 2008). 
 Monitoring.  Asthma is considered an Ambulatory Care Sensitive Condition 
(ACSC) (Barry, 2011) meaning that effective coordination of care may potentially reduce 
the incidence of hospitalization, ED visit and readmission.  Condition monitoring remains 
important once diagnosed and is usually accomplished through primary and home care.  
Poor adherence to treatment regimens remains a common occurrence with rates 
ranging from 30-60% (Dekker, 1993; Gibson, 1995).  Proper use of medications is key  
in preventing exacerbations (HHS, 2007).  Ongoing lung function monitoring both at 
home and in a primary care setting are recommended  as part of a written self-
management plan (Bhogal, 2006). 
 Hospitalization.  Hospitalization for asthma typically occurs when a child 
presents in the ER with a cough, wheezing and/or shortness of breath.  ER and inpatient 
treatment for a potential asthma exacerbation involves use of bronchodilators and a 
regimen of corticosteroids to reduce inflammation and improve lung function (HHS, 
2007).  Patients are often admitted for observation or inpatient hospitalization until lung 
function improves and the child is maintaining good oxygen saturation levels without 
supplemental oxygen.  Typical requirements for hospital discharge are:  (1) stable 
breathing on room air with oxygen saturation rates in the 90s  (2) reduced work of 
breathing and wheezing (3) tolerating oral medications and (4) stabilization of other co-
morbid conditions. 
 Inpatient or observation length of stay for an asthma exacerbation is generally 
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characterized as a function of the time required to improve lung function so that the 
patient can function independently with the appropriate home care and outpatient 
medications.   The time required to stabilize a patient can vary based upon a number of 
factors including patient overall health at admission, the presence of co-morbidities and 
the severity of asthma.  Condition severity is further tied to patient factors noted above 
including genetic pre-disposition, environmental exposures and the effectiveness of 
previous patient self-management and treatment.   Regarding the benefits of hospital 
care, the underlying assumption is that longer hospital stay may reduce the risk of 
relapse by providing a more complete treatment regimen of steroids/inhalers, more 
complete resolution of lung dysfunction, supplemental oxygen, opportunity for patient 
education on self-management/care, removal from the local environment that may be 
exacerbating the condition and better lung function.  
 
STUDY HYPOTHESIS 
 Despite the existing research, estimating readmission risk remains a complex 
endeavor (Kansagara, 2011).   Yet understanding both the underlying clinical and 
economic significance of readmissions, as well as identifying the underlying mechanisms 
available to impact readmissions, is essential to ensuring any reduction efforts are 
effective.   One implicit assumption in efforts to reduce readmissions is that 
readmissions may result from an initial underutilization of hospital resources in providing 
care.  Given this, our primary hypothesis was that an association exists between the 
general utilization of hospital resources and subsequent readmission risk for patients 
with asthma.   Using length of stay as a surrogate for resource utilization (Silber, 2003),  
we tested the association between initial length of stay (ILOS) and readmission risk in 
pediatric asthma patients.  We also examined the association between the difference in 
actual vs. expected length of stay and readmission risk.  Understanding the potential 
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association between resource utilization and the probability of readmission might assist 
pediatric hospitals in evaluating cost-effective approaches to reducing readmissions.  
  
 
MATERIALS AND METHODS. 
 Study Design.  The study design was a retrospective, observational study using 
CHC MN hospital discharge data from January 2008 to August 2012.   We chose the 
observational study design for several reasons.  First, studies regarding readmissions in 
the pediatric population are limited (Gay, 2011).  Use of the observational study design 
method was important in surveying the nature, frequency and potential risk factors 
associated with pediatric readmission as a foundation for further more detailed research.  
Second, the nature of the treatment itself (defined broadly as hospital length of stay) was 
outside the control of the researcher for practical reasons limiting the use of 
experimental methods.  Finally, other potential research methods were not deemed 
practical given financial constraints.  These factors, along with the availability 
retrospective data led to the design selection.   The decision to use a retrospective 
observational study approach introduces certain study limitations that will be discussed 
later.   While observational studies are not designed to provide definitive evidence of 
safety, efficacy or effectiveness, they can be useful in providing evidence of real world 
use and practice, developing future hypothesis for testing and informing clinical practice 
(Nahin, 2012). 
 Setting. MN Children’s is a large, independent children’s hospital system located 
in a large metropolitan area and acts as a safety net hospital, serving the needs of 
poorer, more diverse, multiracial and multilingual residents in the Twin Cities.  Services 
include general inpatient, emergency and home health care, as well as specialty care, 
including ICU, NICU and Cardiac ICU.   Children’s hospital has about 13,000 discharges 
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annually along with 200,000 ER and outpatient visits.   In reviewing hospital discharge 
activity for 2011,  57% of all discharges (80% of all asthma discharges) were from 
Hennepin, Ramsey and Dakota counties which include Minneapolis, St. Paul and the 
Southeast Twin Cities metropolitan area.   This same area accounts for 38% of all 
children under the age of 17 per the 2010 Minnesota census (US Census Bureau, 2010). 
 Measurement Constructs.  Specific measurement constructs to assist in the 
analysis are identified below: 
• Hospital discharge -  Hospital patient and transaction volumes are typically 
measured at the point of hospital discharge (i.e., when the patient is formally 
released from the hospital).   For purposes of this study, both inpatient and 
observation stay discharges (stays under 24 hours) were included given their 
hospital resource impact and separately identified for sensitivity analysis (Macy, 
2012).   
• Length of stay (LOS) –Length of stay is defined as the difference between the 
discharge date and the admit date (date of discharge is not counted), measured as a 
whole number in days.    Same day admits are counted as one day.  Length of stay 
is generally considered a surrogate for measuring resource utilization and care 
(Silber, 2003). 
• Total episode or incident of care – An episode of care is defined generally as the 
care given by a provider for a particular problem or condition over a set period of 
time.   For purposes of this analysis, an “episode of care” is defined as the initial 
admit plus one additional subsequent admit within 30 days, if any.  Only one readmit 
was associated with each admit.  For episodes involving more than one readmit, the 
readmit becomes the index admit for the subsequent hospitalization.  An episode of 
care was measured based upon the count (number of episodes) and duration (using 
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mean length of stay).  This approach is consistent with other readmission research 
(Jencks, 2009). 
• Index admission – Initial admission date for a given episode or incidence of care. 
• Initial length of stay ( ILOS) - Length of stay for an index admission. 
• Expected length of stay (ELOS) – Median initial length of stay by severity level 
• Non-elective readmission  – Unscheduled inpatient readmissions to the hospital 
within a set timeframe from the index admission date.  Estimates of truly preventable 
readmissions in the adult population vary from 5% - 79% of total readmissions 
(median 27%) (van Walraven, 2011).  For purposes of this study, a readmission was 
defined as the first in-patient hospitalization (for reasons other than chemotherapy or 
radiotherapy) initiated within 30 days of discharge following a prior hospitalization.   
• Premature hospital discharge –  Any patient discharge with a length of stay less than 
an expected value, defined as the median length of stay for a given condition 
stratified by case severity.  Readmissions could be for any condition and were not 
limited to asthma, though almost all readmissions following an inpatient 
hospitalization involving asthma were for respiratory-related conditions. 
• Readmission rate – Total non-elective readmissions for the year divided by the total 
eligible inpatient discharges.   
• Length of stay of an episode of care (Episode LOS) –Initial index length of stay plus 
length of stay of the subsequent readmission (Initial LOS + Readmit LOS). 
 
 Data Collection and Preparation.  Hospital discharge data from January 2008 
to August 2012 were drawn from the CHC MN Data Warehouse  which is populated with 
medical and administrative data.  Patient medical records were located on Cerner, the 
hospitals electronic health record system, a stable operating platform that has been in 
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place for 10 years. Demographic data were collected by patient, index admission and 
subsequent readmission.  Readmissions were then linked to index admissions using the 
patient ID and discharge dates.  Data drawn from the warehouse were aggregated and 
analyzed for general reasonableness.     
 Case Identification.  As noted earlier, the spectrum of asthma, including multiple 
phenotypes, the natural history, the determinants, the triggers and pathophysiology can 
make clear diagnosis of the condition difficult.  This can be made increasingly difficult as 
other non-asthma conditions can present with asthma-like symptoms or exacerbate an 
underlying asthma condition.  Critical elements in making a proper diagnosis and 
treatment in younger patients, including a well-documented and accurate case history, 
may not always be readily available. 
 Use of the International Classification of Diseases, Ninth Revision, Clinical 
Modification (ICD-9-CM) principal diagnosis to identify asthma cases is a common 
practice in clinical research.  Identification of asthma using either the principal or 
secondary diagnosis is more common when conducting public health research (Silber, 
2003; Liu, 2009).  Early in the review of asthma cases, it became clear that use of the 
ICD-9 principal diagnosis was potentially problematic and may have introduced a 
significant level of information bias into the results. Hospitals are incented through 
reimbursement guidelines to capture all conditions that the hospital may treat.  However, 
to maximize recoveries, the principal diagnosis usually reflects the most resource-
intensive treatment.  Given that asthma is often a less resource-intensive condition than 
other respiratory conditions, this coding practice may lead to underreporting of asthma 
as the principal diagnosis despite its potential role in the hospitalization of the patient.  
Given the association between condition severity and readmission, failure to identify 
asthma-related hospitalizations when asthma is not the principal diagnosis may prevent 
the identification of more severe asthma cases coded under another principal diagnosis 
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category such as respiratory failure or pneumonia.   Capturing a more complete 
population of probable asthma cases is increasingly important when measuring the 
impact of a particular condition on a hospital’s resources for decision-making purposes. 
 To deal with the limitations involved in use of either the APR-DRG or ICD-9 
classification schemes, a validation study was conducted to validate the identification of 
asthma cases from the discharge file based upon the identification of an ICD-9 code of 
asthma as one of the first five diagnosis code positions for respiratory conditions with a 
known association with asthma.  A 2011 discharge population of potential asthma-
related hospitalizations was drawn from the same children’s hospital system using the 
ICD-9 CM code based upon the presence of an asthma diagnosis as one of the first five 
billing diagnosis (ICD-9-CM 493).  After excluding sickle cell cases and RSV/bronchiolitis 
for patients less than 24 months, the cases were stratified by primary diagnosis for 
known associated respiratory conditions including asthma, pneumonia, respiratory 
failure and RSV/bronchiolitis (n=877).  A random sample (n=87) was drawn from the 
population stratified by respiratory condition and diagnosis coding sequence.  
Identification criteria for asthma-related hospitalizations was developed through 
consultation with a hospital pulmonologist and focused on examining the underlying care 
process administered including a physician diagnosis of asthma, past history of asthma, 
use of relievers/corticosteroids upon admission/discharge with positive response and 
presence of an asthma discharge plan.   A criteria-based medical record review was 
then conducted as a gold standard using this criteria to identify probable asthma cases. 
 A significant association was identified between the diagnosis coding sequence 
for asthma and detection of asthma-related hospitalizations beyond the principal 
diagnosis.  The positive association was highest for asthma diagnosis codes in the 
second (89% of cases identified as asthma cases [95%CI: 0.68-.0.97]) and third coding 
positions (83% of cases identified as asthma cases [95%CI: 0.60-0.94]) before dropping 
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meaningfully for asthma diagnoses included in the fourth and fifth coding positions (21% 
of cases identified as asthma cases [95% CI: 0.09-0.44] and 36% of cases identified as 
asthma cases [95% CI: 0.16-0.62], respectively).   
 Based upon these results, we identified asthma cases for purpose of this study 
using a combination of the APR-DRG code/condition, asthma ICD-9 code position and 
patient age as noted in Table 1.   For example, a five-year old male with pneumonia 
(coded to APR-DRG 139) with asthma as a secondary diagnosis in the second or third 
code position was included in the study.  Applying this identification criteria to the more 
complete population of respiratory cases increased the identification of probable asthma-
related hospitalizations 48% (n=1623 incremental cases).  The use of the broader 
criteria lowered the estimated detection specificity and increased the estimated risk of 
false positive results (i.e., asthma was not a primary underlying reason for 
hospitalization) from 4% to 20%.  A separate variable distinguishing asthma cases that 
were based upon the principal ICD-9 coding and those identified based upon coding of 
asthma in a secondary position was identified for purposes of sensitivity analysis. 
 
 
Table 1 – Asthma case identification criteria 
APR$DRG Asthma,ICD$9 Patient
Principal,Respiratory,Diagnosis Code Code,Position Age
Asthma 141 1$5 All
Pneumonia 139 2$3 All
Respiratory,Failure 133 2$3 All
Respiratory,Ventilation 130 All All
RSV/Bronchiolitis 138 2$3 >24,mos  
 
 Statistical Methods.  The primary statistical methods included both univariate 
and multivariate logistic regression to determine the association of the primary exposure 
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(ILOS) and the binary outcome (readmission).  In analyzing the impact of ILOS on the 
risk of subsequent readmission, an initial descriptive analysis was performed to 
understand the population and to identify any differences in characteristics between 
discharges with and without a readmission.  Categorical covariates were identified based 
upon known factors that may impact readmission including age (grouped by category), 
race, gender, language, hospital proximity (<> 5 miles), admit reason (asthma primary or 
secondary), discharge disposition (home or health agency), season of the year, 
procedure performed, (yes/no) severity of illness (using APR-DRG classification scale 1-
4, with one being minor and 4 being extreme), payer (Commercial, Medicaid/State 
Assistance and Other) and year.    Correlation testing was also performed between all 
possible covariates to determine the presence of any significant co-linearity amongst 
predictor variables.  In an effort to identify any potential confounding or interaction 
variables, univariate logistic regression using a log-transformation was used to test the 
association between potential co-variates and length of stay.  Length of stay is a 
discrete, numeric variable.  LOS is positively skewed with a non-normal distribution 
making the distribution fit challenging.  Researchers generally use a logarithmic 
transformation along with a data trimmed LOS to minimize the extreme values (Ruffieux, 
1993).  
 To test the hypothesis that differences in actual vs expected initial length of stay 
may impact readmission risk, we measured the difference between actual and expected 
initial length of stay (expected initial length of stay was defined as the median length of 
stay set by category of severity).  We grouped discharges into three categories: (1) 
those with an actual ILOS that equalled the expected ILOS, (2) those with an ILOS that 
was less than expected, and (3) those with an ILOS that exceeded the expected value. 
We then applied univariate and multiple logistic regression  to measure the association 
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by category.   We identified potentially significant covariates for further multivariate 
analysis .  
 All multivariate analysis was conducted using a step-wise regression to identify 
all significant covariates for purposes of the primary analysis.   For multivariate 
regression purposes, candidate explanatory variables were identified using a p-value of 
0.10.  Model testing, including goodness of fit, area under the curve (AUC) and variance 
inflation factor (VIF) testing were performed as appropriate.  All remaining tests were 
performed using an α=.05.   All statistical analysis was performed using the statistical 
software Stata (Version 10.0; StataCorp, College Station, Tx). 
 
RESULTS 
  Patient Population.  The patient population included 4,965 patients discharged 
from CHC MN between January 1, 2008 and August 31, 2012 with an identified asthma 
diagnosis as defined.   Among this population, we observed a readmission rate of 3.91% 
(n=194 readmissions).  The CHC asthma population ranged from premature birth to 
adult with the majority of patients between 1-4 years of age (mean age 4.72 years).   
Sixty-one percent (61%) of patients were male which is generally consistent with a 
higher incidence of asthma among boys.  Thirty-three percent (33%) of the cases were 
Black/African-American, including a relatively large population of recent African 
immigrants from Somalia (13.4% of the Black/African-American population declared 
Somali as their primary language – the actual number of Somali patients is probably 
higher).  More than ninety percent (90%) of the patients discharged with asthma had 
mild to moderate asthma severity.  Two thirds (66%) of asthma discharges were 
discharged with asthma as the primary diagnosis.  Mean length of stay was 2.21 days 
(median ILOS 2 days). 
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 Understanding Patient Demographics and Potential Risk Factors for 
Readmission.  A complete demographic breakdown of the study population is noted in 
Table 2, including a univariate analysis of individual risk factors.  Patient characteristics 
were generally consistent among those with and without a readmit.  However, patients 
who were readmitted tended to be younger females with more severe conditions that 
may have required a procedure (i.e., usually mechanical ventilation).   These patients 
were also more likely to be on public assistance.  Significant risk factors for readmission 
in pediatric asthma patients identified through univariate regression analysis included 
case severity, age, procedure performed, season of the year and payer type.  No 
significant collinearity was noted among risk factors (r<0.7). 
 Understanding Potential Risk Factors For Length of Stay.   Log-transformed 
analysis was conducted to understand the association of potential explanatory variables 
on initial length of stay as noted in Table 3.  Risk factors with a significant association to 
ILOS include age, gender, admit reason, patient type, severity, performance of a 
procedure, discharge disposition, season and payer type.   Generally speaking, asthma 
patients with a longer mean length of stay tended to present in the winter months and 
were either very young (<1) or older (>10), female and on Medicaid.  It was more likely 
that these patients had more severe cases and that asthma was not the recorded 
principal diagnosis.  It was also more likely their treatment included a procedure.   
 
 
 
 
 
 
 
	   17	  
Table 2 – Patient demographics and potential risk factors for readmission 
Description n Overall
Discharge Initial Discharge Asthma 4965
Age Overall (Continuous) 4965 100.0%
<1 339 6.8%
1-4 year 2621 52.8%
5-9 yrs 1301 26.2%
10-14 yrs 525 10.6%
15-17 yrs 150 3.0%
18+ yrs 29 0.6%
Race White/Caucasian 1864 37.5%
Black/African-American 1641 33.1%
Other 1460 29.4%
Gender Female 1931 38.9%
Male 3034 61.1%
Language English 4212 84.8%
Spanish 347 7.0%
Somali 233 4.7%
Other 173 3.5%
Hospital Proximity <5 miles 2273 45.8%
>5 miles 2692 54.2%
Admit Reason Asthma Primary 3342 67.3%
Asthma Secondary 1623 32.7%
Patient Admit Type Observation 881 17.7%
Inpatient 4084 82.3%
Admit Day Weekday 3655 73.6%
Weekend 1310 26.4%
Case Severity Minor (with observation stays) 1740 35.0%
Moderate 2757 55.5%
Major 440 8.9%
Extreme 28 0.6%
Procedure Procedure Performed 117 2.4%
No Procedure 4848 97.6%
Actual vs Expected ILOS Acutal<Expected 857 17.3%
Actual=Expected 2396 48.3%
Actual>Expected 1712 34.5%
Discharge Disposition Home/Self-Care 4953 99.8%
Death/AMA 12 0.2%
Admit Season Winter (Dec-Feb) 1075 21.7%
Spring (Mar-May) 1391 28.0%
Summer (Jun-Aug) 884 17.8%
Fall (Sep-Nov) 1615 32.5%
Admit Year 2008 1051 21.2%
2009 1227 24.7%
2010 994 20.0%
2011 1009 20.3%
Payer Commercial 2176 43.8%
Medicare/Medicaid 2703 54.4%
None 86 1.7%
The odds ratio measures the difference in readmission rates by characteristic.  Reference values for categorical variables are noted with a "-" in the OR (95% CI) column.
 % Total Population
No Readmit
100.0%
6.4%
53.0%
26.5%
10.6%
2.9%
0.6%
37.6%
32.9%
29.4%
38.7%
61.3%
84.9%
7.0%
4.6%
3.5%
45.7%
54.3%
67.2%
32.8%
17.9%
82.1%
73.5%
26.5%
35.2%
55.7%
8.6%
0.5%
2.2%
97.8%
17.2%
48.4%
34.4%
99.7%
0.3%
21.5%
28.0%
18.1%
32.4%
21.2%
24.7%
20.0%
20.1%
44.3%
54.0%
1.8%
Readmit
With Readmit Rate OR (95% CI)
3.9%
100.0% 3.9% 0.98 (0.95-1.02)
16.5% 9.4% 2.80 (1.84-4.26)
48.5% 3.6% -                      
18.0% 2.7% 0.74 (0.50-1.10)
9.3% 3.4% 0.95 (0.57-1.59)
6.7% 8.7% 2.55 (1.39-4.63)
1.0% 6.9% 1.99 (0.47-8.49)
35.1% 3.6% -                      
35.6% 4.2% 1.16 (0.82-1.63)
29.4% 3.9% 1.07 (0.75-1.54)
42.8% 4.3% 0.85 (0.63-1.13)
57.2% 3.7%
83.5% 3.8% -                      
7.7% 4.3% 1.12 (0.66-1.94)
6.7% 5.6% 1.47 (0.83-2.64)
2.1% 2.3% 0.59 (0.22-1.61)
47.4% 4.0% 1.07 (0.80-1.43)
52.6% 3.8%
69.1% 4.0% 1.09 (0.80-1.48)
30.9% 3.7%
13.4% 3.0% 0.70 (0.47-1.08)
86.6% 4.1%
75.8% 4.0% 0.89 (0.64-1.24)
24.2% 3.6%
30.9% 3.4% -                      
52.1% 3.7% 1.06 (0.77-1.47)
16.0% 7.0% 2.12 (1.35-3.32)
1.0% 7.1% 2.15 (0.50-9.28)
5.7% 9.4% 2.64 (1.40-5.01)
94.3% 3.8%
19.1% 4.3% 1.21 (0.82-1.80)
44.3% 3.6% -                      
36.6% 4.1% 1.16 (0.84-1.60)
100.0% 3.9% na
0.0% 0.0%
25.3% 4.6% 2.06 (1.21-3.50)
27.8% 3.9% 1.74 (1.03-2.94)
10.3% 2.3% -                      
36.6% 4.4% 1.99 (1.20-3.29)
20.1% 3.7% -                      
24.2% 3.8% 1.03 (0.67-1.59)
20.1% 3.9% 1.06 (0.67-1.66)
25.3% 4.9% 1.32 (0.86-2.03)
33.0% 2.9% -                      
66.0% 4.7% 1.64 (1.20-2.23)
1.0% 2.3% 0.79 (0.19-3.26)
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Table 3 – Analysis of potential risk factors for length of stay 
Mean
Risk Factor Description n % ILOS p-value
Discharge Initial Discharge Asthma 4965 100.0% 2.21          
Age <1 339 6.8% 2.51          -               
1-4 year 2621 52.8% 2.09          <.001
5-9 yrs 1301 26.2% 2.12          <.001
10-14 yrs 525 10.6% 2.69          0.394           
15-17 yrs 150 3.0% 2.41          0.990           
18+ yrs 29 0.6% 2.93          0.777           
Race White/Caucasian/Other 1864 37.5% 2.14          -
Black/African American 1641 33.1% 2.23          0.102           
Other 1460 29.4% 2.27          0.004           
Gender Female 1931 38.9% 2.31          <.001
Male 3034 61.1% 2.14          
Language English 4212 84.8% 2.21          -               
Spanish 347 7.0% 2.21          0.771           
Somali 233 4.7% 2.15          0.391           
Other 173 3.5% 2.22          0.616           
Hospital Proximity <5 miles 2273 45.8% 2.18          0.505           
>5 miles 2692 54.2% 2.24          
Admit Reason Asthma Primary 3342 67.3% 1.90          <.001
Asthma Secondary 1623 32.7% 2.85          
Patient Admit Type Observation 881 17.7% 1.10          <.001
Inpatient 4084 82.3% 2.45          
Day Weekday 3655 73.6% 2.24          0.089           
Weekend 1310 26.4% 2.11          
Severity Minor (including observation stays) 1740 35.0% 1.44          -               
Moderate 2757 55.5% 2.39          <.001
Major 440 8.9% 3.65          <.001
Extreme 28 0.6% 9.32          <.001
Procedure Yes 117 2.4% 6.63          <.001
No 4848 97.6% 2.10          
Discharge Disposition Home/Self Care 4953 99.8% 2.20          -               
AMA 7 0.1% 1.43          <.001
Death 2 0.0% 8.00          <.001
Other Facility 3 0.1% 6.67          <.001
Admit Season Winter (Dec-Feb) 1075 21.7% 2.44          -               
Spring (Mar-May) 1391 28.0% 2.19          0.006           
Summer (Jun-Aug) 884 17.8% 2.09           <.001 
Fall (Sep-Nov) 1615 32.5% 2.13           <.001 
Admit Year 2008 1051 21.2% 2.10          -               
2009 1227 24.7% 2.24          0.039           
2010 994 20.0% 2.20          0.324           
2011 1009 20.3% 2.33          0.100           
Payer Commercial 2176 43.8% 2.06          -
Medicare/Medicaid 2703 54.4% 2.32          <.001
None 86 1.7% 2.10          0.843           
Reference values for testing significance of categorical variables noted in p-value column with '-'.
Admit year excludes partial year 2012 results.  
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 Identification of Significant Covariates.  The results of bivariate logistic 
regression  identified four significant risk factors addressed in the final multivariate 
analysis:  case severity,  procedures, payer type and age.  Similar testing of covariates 
associated with ILOS were also completed as noted in Table III.  The results of this 
testing identified additional risk factors including gender, admit reason, admit type 
(observation vs inpatient) and season that were associated with ILOS.  These risk 
factors are discussed briefly below. 
 Severity.  Patients with a severity categorization of major were almost twice as 
likely to be readmitted as patients categorized as mild (2.12 [95% CI: 1.35-3.31]).  More 
generally the risk of readmission increased as patient severity increased by category.  
The increase in severity was also associated with a significant increase in ILOS.  Both 
factors suggest that severity may have either a a significant confounding or effect 
modification on the relationship between ILOS and readmission risk.    
 Other factors that may be associated with severity were also noted in examining 
ILOS.   Season was shown to significantly impact ILOS with the highest mean LOS in 
the winter months  and the lowest mean LOS in the summer months (2.44 vs 2.19 days; 
p<.001), consistent with other studies. Similarly significant differences in ILOS were 
noted for cases where asthma was the principal vs secondary diagnosis (1.90 vs 2.85 
days; p<.001).  Asthma not coded as the principal diagnosis suggests the increased 
presence of other comorbidities that can increase ILOS.  Both the impact of seasonality 
and diagnosis on ILOS were also consistent with other study findings (Soyiri, 2011).  
Finally, the type of admission (observation vs inpatient stays) is directly associated with 
severity.  For purposes of this study, all observation stays were classified as mild 
severity.  Be definition, inpatient stays were significantly longer. 
 Procedures.  The significant difference in readmission rates for procedures was 
not unexpected.  Cases including the performance of a surgical procedure during stay 
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represented 2.2% of total cases in the population (n=117).  The peformance of a 
procedure during the stay (almost by definition) is associated with increased case 
severity.  Of the procedures performed,  58% involved non-invasive (n=25) or 
continuous (n=43) mechanical ventilation and 13% (n=15) involved a bronchial biopsy.  
Patients who had a procedure performed during their stay had a 2.5 times greater risk of 
readmission (OR 2.64 [95% CI: 1.40-5.01]) and had a significantly higher mean ILOS 
(4.53 day longer) than those that did not have a procedure.   
 Race and Payer Type.  Despite the higher prevalence of asthma among non-
hispanic black children in the hospital population, no significant direct differences in 
readmission rates by race were noted when comparing black/African-Americans  (4.2%) 
with whites (3.8%) and other non-black minority groups (3.9%).  Mean ILOS between 
black/African-Americans and whites was not significantly different which differs from the 
results of other studies which point to a correlation between race and LOS for asthmatic 
patients (Samuels, 1998; Soyiri, 2011).  A significant difference was noted between 
whites and all other categories as grouped.  Mean ILOS was higher among Asians, 
Native Americans and bi-racial groups relative to whites.  Analyzing these groups 
individually, only Native Americans had a significantly different ILOS relative to whites 
(3.00 days vs 2.14 days (p<.001).  The overall sample of identified Native Americans 
was relatively small (n=91). 
 Race is often linked to socio-economic status and payer type.  This study did not 
find a strong correlation between race and payer type (r=.39).  Medicaid/Medicare 
recipients had a significantly higher risk of readmission than commercial and self-insured 
patients (OR 1.64 [95% CI: 1.20-2.23]).  Medicaid/medicare patients also had a longer 
mean LOS.  The lack of a significant association between race and readmission or 
length of stay among Black/African-Americans may be the result, in part, of the 
characteristics of this specific population.  This particular hospital discharge population 
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includes a significant number of recent African immigrants from Somalia who may 
possess distinctly different health characteristics than the African-American population in 
general.   More research is needed to understand the impact of this distinct population. 
 Age.  While age was not a significant risk factor for readmission when measured 
as a continuous variable, significant categorical differences were noted when grouped.   
Significant differences in readmissions rates were noted among children <1 yr of age as 
well as children 15+ years old relative to children between the ages of 1 and 15.   Both 
these groups had a smaller sample of both admissions and readmissions (<1yr; admits 
n=309, readmits n=32; >15 yr admits n=179, readmits n=15).  Children under 1 year old 
as well as children 10 years and above also had significantly higher mean LOS.  In 
evaluating the results, the higher readmission rates among very young children (<1 yr) 
may be associated with the high prevelance of wheezing and other respiratory 
conditions among very young children due to continued lung and respiratory 
development, as well as diagnostic uncertainty associated with the condition in infants.   
For older children (15-17 years) the higher readmission rates may suggest that older 
children who continue to receive care at Childrens (vs another hospital) have more 
severe asthma including other co-morbidities and that patients are self-selecting to 
receive treatment at CHC MN.  The other potential explanation for the higher 
readmission rates among older teens is that as children age, they take on more 
responsibility for managing their asthma care.  Challenges with self-management of 
asthma care could also be impacting the readmission rates for older youth. 
 Gender.  No significant differences in readmission rates were noted by gender.  
A significant difference in ILOS was identified based upon gender with females having a 
significantly higher mean ILOS than males (2.31 vs 2.14 days; p<.001).   This is 
consistent with at least one recent study in the UK that identified a significantly higher 
LOS between females and males of all ages (1.11 times longer [95% CI: 1.09-1.13]).   
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Speculative reasons for the differences may include case severity, recovery timing or 
other factors.  More research is needed to better understand the factors driving 
increased LOS in female asthma patients (Soyiri, 2011). 
 Evaluating ILOS and Readmission Risk.  Univariate logistic regression 
analysis of ILOS (in days) indicated a 7% (OR: 1.07 [95%CI 1.02-1.12]) increased risk of 
readmission with each additional day a patient stays in the hospital.  In multivariate  
analysis adjusting for risk factors including severity, payer type, procedure status and 
age, the association between ILOS and readmission risk remained positive at 3.6% but 
the results were no longer significant (OR: 1.04,[95%CI: .98-1.10]).  Results of the 
multivariate analysis are summarized in Table 4.  Pseudo r-square for the model was 
.0361.  GOF testing was not significant (.8855).  AUC measured at .650.  VIF results 
showed no significant colinearity (all VIF <2).  
 
Table 4 – Final multivariate model results 
Odds Ratio SE z P>|z| LL UL
ILOS 1.04             0.03 1.15 0.25 0.98             1.10             
Severity (vs mild severity):
Moderate 0.98             0.17 -0.12 0.90 0.70             1.36             
Major 1.71             0.42 2.17 0.03 1.05             2.76             
Extreme 0.66             0.59 -0.46 0.64 0.12             3.74             
Age group (vs age group 1-4):
<1 2.58             0.55 4.39 0.00 1.69             3.93             
5-9 0.72             0.15 -1.63 0.10 0.48             1.07             
10-14 0.88             0.23 -0.50 0.62 0.52             1.47             
15-17 2.52             0.78 2.97 0.00 1.37             4.64             
18+ 1.61             1.21 0.63 0.53 0.37             6.99             
Payer (vs commercial payer):
Medicare/Medicaid 1.59             0.25 2.97 0.00 1.17             2.18             
None 0.92             0.67 -0.11 0.92 0.22             3.87             
Procedure 1.89             0.73 1.65 0.10 0.89             4.04             
Reference values for categorical variables are noted in parenthesis.
95% CI
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Evaluating ILOS and Readmission Risk Categorically By Day.  Further analyzing 
ILOS categorically by day, one-day stays had an increased risk of readmission (OR: 
1.27[95% CI: 0.87-1.85]) over two-day stays, which had the lowest overall readmission 
rate.  Observed differences in readmission rates were not significant.  The observed 
readmission rate increased slightly as ILOS extended beyond two days as noted in 
Figure 1, but that increased rate was not statistically different from the readmission rate 
for discharges with an ILOS of two days (OR= 1.68[95% CI: 0.82-3.46]).    
 
Figure 1 – Readmission rate by initial length of stay (in days) 
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Similarly, the readmission rate for a one-day length of stay was slightly higher but that 
observed difference was well within confidence limits when compared with the median 2-
day ILOS as noted in Table 5. 
Table 5 – Final multivariate results categorized by day 
Description n Overall
Overall 4965 100.0%
1 Day 1870 37.7%
2 Days 1736 35.0%
3 Days 727 14.6%
4 Days 321 6.5%
5 Days 139 2.8%
6+ Days 172 3.5%
The odds ratio measures the difference in readmission rates by day with the median ILOS of 2 days as the reference category.
ILOS (by Category)
 % Total Population
No Readmit
100.0%
37.7%
35.1%
14.6%
6.4%
2.7%
3.4%
Readmit Adjusted
With Readmit Rate OR 95% CI
100.0% 3.9% 1.04 [0.98-1.10]
36.6% 3.8% 1.27 [0.87-1.85]
30.4% 3.4% -                      
14.9% 4.0% 1.07 [0.68-1.70]
7.2% 4.4% 1.11 [0.60-2.04]
5.2% 7.2% 1.68 [0.82-3.46]
5.7% 6.4% 1.11 [0.53-2.35]
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 Testing for Effect Modification.   We stratified our sample by category of 
severity in order to test for effect modification.   The readmission risk associated with 
length of stay differed by severity level but was not significant on both an unadjusted and 
adjusted basis as noted in Table 6.  
 
Table 6 – Impact of ILOS on readmission risk by severity level 
Level ILOS(OR 95%(CI ILOS(OR 95%(CI
Mild 0.88(((((((((((( .60*1.29 0.82(((((((((((( .55*1.21
Moderate 1.09(((((((((((( .96*1.23 1.00(((((((((((( .88*1.15
Major 0.97(((((((((((( .84*1.12 0.93(((((((((((( .79*1.09
Extreme 1.09(((((((((((( 1.00*1.19 na na
Unadjusted Adjusted
 
  
 Assessing Expected vs Actual Length of Stay and Readmission Risk.  To 
refine our measurement of possible early hospital discharge, we compared the actual to 
expected length of stay by readmission type, adjusting for severity.  We found that 
patients who were discharged as expected (the difference in actual vs expected ILOS 
was zero) had the lowest observed readmission risk (3.6%).  Patients who were 
released either earlier or later than expected had a higher readmission risk (OR: 1.21 
[95% CI: 0.82-1.79]) and (OR: 1.16 [95% CI: 0.84-1.60]), respectively, than those 
released as expected as noted in Figure 2.  However, the associations were not 
significant.  Though the observed value dropped for patients released later than 
expected, the lack of a statistical association remained upon further adjusting for known 
covariates  (actual<expected - OR: 1.13 [95% CI: 0.74-1.71]; actual>expected - OR: 
0.97 [95% CI: 0.69-1.38]). 
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Figure 2 - Observed readmission risk by difference in actual vs expected ILOS 
 
 
DISCUSSION 
 Our study objective was to determine what association may exist between initial 
hospital resource utilization and the risk of readmission.  To test this, we evaluated two 
measurements of hospital resource utilization.   The first measurement looked at ILOS 
more generally and by day.  The second measurement categorized patients into three 
subgroups based upon whether their ILOS was shorter than, in line with or longer than 
the expected ILOS.  
 Contrary to our initial expectations, after adjusting for known confounders, we 
found no significant association between ILOS and readmission risk (OR: 1.04 [95% CI: 
0.98-1.10]).  These findings are similar with at least one study on the adult population 
that found that increasing LOS did not affect the likelihood of readmission across all 
conditions (Johnson, 2012).  One study of readmission risk factors among inner-city 
children in the Bronx with asthma also found no association between ILOS and 
readmission risk (OR 1.08 [95% CI: 0.97-1.21]) (Reznick, 2006).     
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 The lack of association between ILOS and readmission risk could also be seen 
analyzing LOS categorically by day.  The difference in risk for different values of LOS 
was not statistically different from the risk of readmission for the median LOS of two 
days.   In categorically analyzing the association between the difference in actual vs 
expected length of stay,  we found that the observed difference in readmission risk for 
patients was highest for those that had either a shorter or longer than expected ILOS, 
but the association was not significant.  This lack of association remained after adjusting 
for covariates, indicating that patients who were released earlier than anticipated did not 
have a significantly different risk of readmission. 
 These findings have several implications.  First, use of the ICD-9 principal 
diagnosis code or the APR-DRG code for asthma detection understates the real burden 
of asthma within a hospital population.  Early in the review of asthma cases, we found 
the use of the ICD-9 principal diagnosis introduced information bias into the results.  
Hospitals are incentivized through reimbursement guidelines to capture all conditions 
that the hospital treats during a patients stay.  However, to maximize payments, the 
principal diagnosis usually reflects the most resource-intensive treatment.  Given that 
asthma may be less resource-intensive than respiratory failure or other conditions, this 
can lead to underreporting of asthma as the principal diagnosis despite clear evidence of 
asthma treatment and its major role in the illness.  With a higher mean ILOS (2.85 days 
vs. 1.90 days; p<.001) for asthma cases with a secondary ICD-9 diagnosis, capturing the 
more complete population of treated asthma cases increased the number of asthma 
patient days 4625 or 73%.  Assuming a daily charge of $5000, the potential financial 
scope of asthma-related hospitalizations would increase meaningfully in this population 
from $6.8M to $11.8M annually, increasing the potential impact of efforts to reduce 
asthma hospitalizations. 
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 Second, overall asthma readmission levels are relatively low when compared to 
the adult asthma population.   The CHC MN readmission rate of 3.91% we measured 
over four years is generally consistent with national data which estimated pediatric 
asthma readmissions at 3.2%,  This is in contrast to adult asthma 30-day readmission 
levels that range from 11.8% to 17.3%, increasing with age (Jencks, 2009; HHS, 2013).  
This suggests that the opportunity to lower cost and improve outcomes through reducing 
readmissions is much lower in the pediatric population than in the adult population.   
 Third, the lack of association between ILOS and readmission risk suggests that 
days counted in an episode of care length of stay are not exchangeable.   As a result, 
altering initial length of stay in an effort to reduce the risk of readmission will likely have a 
limited impact in reducing episode of care length of stay for pediatric asthma patients.  
For example, based upon our findings, increasing all one-day visits in the study to two-
day visits would increase hospital patient days by 38% in this cohort  (1870 days) while 
decreasing total readmissions by only 3.8% [95% CI: 3.6-4.0%].  This translates into 
1870 additional days to eliminate 7 readmissions with a savings of 18-20 days of readmit 
length of stay, resulting in a net increase of 1850 days of hospitalization.  
  
STUDY LIMITATIONS 
 Several factors may impact the internal and external validity of study results.   
 Use of Observational Study Methods.  Use of an observational study method 
can increase the risk of potential confounding compared to the use of experimental 
methods.   Efforts to assess and minimize the impact of potential confounding factors 
were addressed through a detailed analysis of known confounding factors for 
association with the exposure and outcome variables.    
 Single Hospital System.  Approximately 25% of children’s hospitalizations in the 
US are at children’s hospitals (Marenstein, 2005).  This study was conducted within a 
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single independent children’s hospital system with a set of potentially distinct 
characteristics from general hospitals including the urban setting, patient demographics, 
the nature and severity of conditions treated and any distinct asthma treatment protocols 
or clinical pathways in place. Evidence suggests that median LOS may not vary 
significantly between childrens hospitals and general hospitals though study results are 
mixed (Muerer, 1999; Marenstein, 2005).   Patterns of care and readmission rates for 
asthma between children’s hospitals and general hospitals in the NY/PA region were 
shown to be consistent after adjusting for certain covariates (Silber, 2003).  Care should 
be taken in applying these results more generally across the pediatric population. 
 Case Identification Methods.  The identification of asthma cases including 
respiratory cases with a secondary diagnosis code of asthma increased the sensitivity 
and overall accuracy in detecting asthma cases, but also lowered the detection 
specificity and increased the accuracy of case identification from 52% to 83%.  The risk 
of false positive results increased from 4% to 20%.  Given the volume and nature of 
asthma cases excluded through use of the primary diagnosis code alone, use of the 
refined criteria led to a more complete count and seemed a reasonable trade-off to 
obtain a better measure of the impact of asthma on hospital resources.    
 Other Known Confounding Factors.  Known confounding factors identified in 
adult readmission studies include readmission to a different hospital, the nature of post-
discharge primary care, medical indigence and discharge against medical advice 
(DAMA) (Ashton, 1996).   The incidence of DAMA was immaterial (n=7, 0.14%).  
Regarding medical indigence,  1.7% of identified cases had no insurance.   While the 
percentage of children covered by insurance was higher than for the general adult 
population in Minnesota, the percentage of children with coverage is significantly lower 
than the approximately 6.1% of children in Minnesota without insurance (CDF, 2012).  
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Uninsured patients have been shown to have distinct demographic characteristics that 
are not fully addressed in this study.  
 Selection Bias and Loss To Follow Up.  Readmission to a different hospital 
may also introduce study bias given that asthma patients readmitted to CHC MN self-
select for readmission and may be lost to follow up.    This could lead to understating the 
true readmission rate related to hospital care in the population and remains a challenge 
in readmission studies.  To estimate the potential impact of CHC MN discharges 
readmitted to a different hospital within 30 days, a CHC MN preliminary analysis using 
data for 2011 (n=207 readmits) from a local payer determined that 10% of these cases 
readmitted for all causes were readmitted to a non-CHC MN hospital.  Increasing the 
actual readmission volume by 10% did not materially change the calculated readmission 
rate of 3.91% (95% CI 3.36-4.44%).   Given that children treated at childrens hospitals 
have a higher prevalence of single or multiple complex co-morbid conditions 
(Marenstein, 2005; Silber 2003), cases being readmitted to CHC MN may have 
characteristics that differ from those who seek readmisson elsewhere and thus were not 
included as readmissions.   As a result, the overall readmission rate for this study may 
be understated and the case mix associated with readmissions as part of this study may 
differ from the general population. 
  
CONTRIBUTION AND FUTURE DIRECTIONS 
 Understanding pediatric readmissions remains a complex endeavor.  The 
primary contribution of this study is to demonstrate that no strong association exists 
between initial length of stay as a measure of hospital resource utilization and the risk of 
readmission for pediatric asthma patients.  More research is needed to further validate 
these results across multiple centers.  These findings have potential implications for both 
payers and hospitals working to implement accountable care programs.  Given the 
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significantly lower readmission rates for pediatric care, payors may need to re-examine 
the use of readmissions as an impactful measure of inpatient hospital care for childhood 
conditions such as pediatric asthma.  Other factors outside hospital care, such as 
environment, condition severity, and so forth, have a more significant impact on 
readmission risk than the quantity of inpatient care and should be examined in setting 
separate incentive policies for childrens hospitals (Morse, 2011).    
 Researchers have argued that preventing rehospitalizations for pediatric asthma 
requires a more concerted effort by hospitals to influence those factors that can change 
behavior outside the hospital, beginning with better coordination between the hospital 
and the primary care organizations (Vest, 2010; Feigenbaum, 2012) and improved 
patient self-management (Reindal, 2006). Research should be done to evaluate how 
quantitative discharge guidelines aimed at lowering readmissions can be embedded into 
an electronic health record (EHR) checklist as part of the discharge planning process to 
identify potential high-risk patients for follow up care.   Targeted, innovative uses of 
technology to improve primary care coordination and better monitor patient self-care 
following discharge should be further examined as a potentially more cost-effective 
method for minimizing readmission risk. 
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